GF-DUAL 10mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.

For research use only — not for human or veterinary use.

Product Overview

GF-DUAL is a synthetic research peptide studied in controlled laboratory environments for its interaction with dual metabolic receptor pathways and endocrine signalling cascades. This lyophilized 10 mg preparation is supplied in a sealed research vial and supports reproducible in vitro experimentation and analytical validation.

Scientific Background

GF-DUAL belongs to a class of receptor-active peptides investigated in metabolic pathway modelling and signal-amplification research. These peptides are frequently used in laboratory studies to examine receptor-binding behaviour, intracellular cascade activation and coordinated signalling across multiple regulatory systems.

Due to its defined molecular structure and reproducible chromatographic profile, GF-DUAL is incorporated into experimental models focused on metabolic communication pathways and receptor-mediated biochemical processes.

Research Context

Research into dual-receptor metabolic peptides expanded significantly during the 2010s as laboratories explored complex signalling systems involved in energy regulation and feedback-controlled biochemical cascades. GF-DUAL is utilised within this framework as a reference compound for dual-pathway interaction modelling under controlled experimental conditions.

Mechanistic Focus in Research

• Dual metabolic receptor interaction analysis
• Endocrine signalling cascade modelling
• Receptor-binding and activation dynamics
• Comparative structure–function evaluation
• Controlled in vitro metabolic research studies

Analytical Verification (COA)

Independent Liquilabs analysis confirms validation for Batch GF082025002. Key analytical results include:

• Assay Content: 10.22 mg
• Identification – Retention Time: 0.99
• Identification – Spectrum: 997
• Purity: greater than 99.8 percent
• Endotoxins: less than 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected
• Heavy Metals: not detected including arsenic, cadmium, cobalt, lead, nickel, mercury and vanadium

All analytical values were obtained using validated chromatographic, spectroscopic and microbiological procedures. Results relate only to the tested sample batch.

Research Applications

• Metabolic pathway modelling
• Dual receptor signalling research
• Biochemical cascade evaluation
• Comparative metabolic peptide studies
• Controlled laboratory investigations

Grail Formula Quality

Every Grail Formula research peptide undergoes independent third-party laboratory testing for identity, assay accuracy, purity and microbial safety. Each batch is verified for analytical consistency and reproducibility to support reliable scientific research outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptide materials with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment
• Supplied for human investigational use

Independently verified by Liquilabs s.r.o. (Czechia)
Validated assay content 10.22 mg
Purity greater than 99.8 percent
Retention time and spectral identity confirmation
Endotoxin levels below 0.001 EU per mg
No detectable microbial contamination
No detectable heavy metals
EU shipments include bacteriostatic water
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.